| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 05/06/2010 | WO2010049455A1 Process for preparing nebivolol |
| 05/06/2010 | US20100113584 Novel use of (-)-epigallocatechin gallate |
| 05/06/2010 | US20100112622 Method for detecting phenothiazine-derivative color and color-developer reagent used therein |
| 05/06/2010 | DE102009043436A1 Flüssigkristallanzeige Liquid-crystal display |
| 05/06/2010 | CA2741862A1 Compositions containing delta-9-thc-amino acid esters and process of preparation |
| 05/06/2010 | CA2737340A1 Process for preparing nebivolol |
| 05/05/2010 | EP2181096A1 Use of rylene derivatives as active components in solar cells and photodetectors |
| 05/05/2010 | EP1866699B1 Photochromic materials with reactive substituents |
| 05/05/2010 | EP1115398B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 05/05/2010 | CN1889847B Package drink |
| 05/05/2010 | CN101701013A Method for extracting proanthocyanidin from pine bark by taking water as solvent |
| 05/04/2010 | US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 05/04/2010 | US7709663 e.g lithium-bis[1,2-benzenediolato(2-) O,O']borate(1-), used as catalyst and an electrolyte for rechargable lithium batteries |
| 04/29/2010 | WO2010045674A1 Methods for inducing programmed cell death |
| 04/29/2010 | US20100105930 Process for the production of alpha-tocotrienol and derivatives |
| 04/29/2010 | US20100105767 Compounds, compositions and methods |
| 04/29/2010 | US20100105725 Antidiabetic bicyclic compounds |
| 04/29/2010 | US20100105700 Decahydro-1h-indenoquinolinone and decahydro-3h-cyclopentaphenanthridinone cyp17 inhibitors |
| 04/29/2010 | US20100105095 Optical Molecular Sensors for Cytochrome P450 Activity |
| 04/28/2010 | EP2179996A1 Sulfonated diarylrhodamine dyes |
| 04/28/2010 | EP2179994A1 Fused bicyclic compound |
| 04/28/2010 | CN1676521B Kuh-seng ketone and its derivative and the like and use in preparing anti-tumor medicine |
| 04/27/2010 | US7705039 Method for treating sleep apnea |
| 04/27/2010 | US7704756 Such as acylated fluorescein dye for use as reporter molecules for detecting cell entry by molecules; detectable signal upon uptake by a cell; high throughput screening; solid phase synthesis |
| 04/27/2010 | US7704284 thiol dyes; use in dyeing of organic materials, such as keratin fibers, wool, leather, silk, cellulose or polyamides, especially keratin-containing fibers, cotton or nylon, and preferably human hair |
| 04/22/2010 | WO2010045551A1 Xanthenone-4-acetic acid derivatives |
| 04/22/2010 | WO2010045402A1 Trpv1 antagonists |
| 04/22/2010 | WO2010045401A1 Trpv1 antagonists |
| 04/22/2010 | WO2010045270A2 Compositions for labeling and identifying autophagosomes and methods for making and using them |
| 04/22/2010 | WO2010045258A2 Spirocyclic gpr40 modulators |
| 04/22/2010 | WO2010043749A1 Composition for treatment of metabolic syndrome |
| 04/22/2010 | WO2010043000A1 S1p receptors modulators and their use thereof |
| 04/22/2010 | WO2009151770A3 Colchicine solid-state forms; methods of making; and methods of use thereof |
| 04/22/2010 | US20100099786 Carbamate, thiocarbamate or carbamide comprising a biomolecular moiety |
| 04/22/2010 | US20100099755 Chemotherapeutic flavonoids, and syntheses thereof |
| 04/22/2010 | US20100099754 5,6-dimethyl xanthone-4-acetic acid derivatives and method of preparing the same |
| 04/22/2010 | US20100099752 Pharmaceutical composition containing bicyclic type compounds |
| 04/22/2010 | CA2740484A1 S1p receptors modulators and their use thereof |
| 04/22/2010 | CA2739888A1 Spirocyclic gpr40 modulators |
| 04/22/2010 | CA2737775A1 Trpv1 antagonists |
| 04/22/2010 | CA2737768A1 Trpv1 antagonists |
| 04/21/2010 | EP2177505A1 Bicyclic acylguanidine derivative |
| 04/21/2010 | EP2175862A1 Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds |
| 04/21/2010 | EP1776354B1 A novel process for preparation of nebivolol intermediates |
| 04/21/2010 | EP1258252B1 Integrin expression inhibitors |
| 04/21/2010 | CN101696201A Method for preparing catechins |
| 04/21/2010 | CN101157733B Method for abstracting dihydroquercetin and arabinogalactan from larch and processing residual thereof |
| 04/21/2010 | CN101074258B Method for separating and extracting phytosterin and Vitamin E from soyabean deodorization distillate |
| 04/21/2010 | CN101041652B Separating purified new bisflavone compound from dragon's blood and preparation method thereof |
| 04/20/2010 | US7700646 Compounds for use in the treatment of infection |
| 04/20/2010 | US7700584 antitumor agents; viricides |
| 04/20/2010 | US7700368 plant extracts; obtaining ethanolic solution, passing through column of activated charcoal, and collecting the eluate, removing solvent by rotary evaporation, redissolving in methanol, filtering |
| 04/20/2010 | CA2319680C Compounds and compositions for delivering active agents |
| 04/20/2010 | CA2279331C Compounds and compositions for delivering active agents |
| 04/15/2010 | WO2010042867A2 Activators of human pyruvate kinase |
| 04/15/2010 | US20100094012 Heterodiamondoids |
| 04/15/2010 | US20100093955 Photoreactive polymer and method for preparing the same |
| 04/15/2010 | US20100093843 Novel nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of cartilage degradation or cartilage damage in joints |
| 04/15/2010 | US20100092995 Fluorescent ruthenium compounds for detecting calcium binding proteins |
| 04/15/2010 | CA2740148A1 Activators of human pyruvate kinase |
| 04/14/2010 | EP1260508B1 Reagents for the quantitation of active oxygen |
| 04/14/2010 | CN101694487A Screening method, extracting method, content measuring method and application of glycyrrhisoflavone in liquorice |
| 04/14/2010 | CN101693705A Phenol compound as well as preparation method and applications thereof |
| 04/14/2010 | CN101129353B Use of 7-hydroxyl-3-[(4-hydroxyl)-3-(3-methyl- butyl-2- alkenyl) phenyl]-4H-1-benzopyran-4-ket |
| 04/14/2010 | CN101062926B Preparation and usage of unnatural 3,4-dihydro isocoumarin derivatives |
| 04/13/2010 | US7696364 alkenylated aromatic compounds featuring at least one hydroxy group, their ring-closure reactions to chroman derivatives; manufacture of tocols, tocopherols and their alkanoates such as alpha -tocopherol (TCP) and alkanoates; indium salt as the catalyst |
| 04/13/2010 | US7696363 reduction of Diaidzein Diacetate in presence of carbon supported palladium hydroxde reduction catalyst (Pearlman's catalyst) and hydrazine or ammonium formate reducing agent to form equol |
| 04/13/2010 | US7696246 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 04/13/2010 | US7696245 Pyridylalkyl-amino-substituted spiro(phthalan-1,9'-xanthene) or xanthene compounds that complex zinc; can measure zinc ions with high sensitivity without damaging cells; can measure fluorescence with a long wavelength excitation light |
| 04/13/2010 | US7696186 7,9-substituted tetracycline compounds |
| 04/13/2010 | US7695736 Powder of 30-90% a water-soluble cycloxygenase inhibitor, 5-60% of a buffer and 0-10% of other excipients |
| 04/13/2010 | CA2447637C Uncatalysed addition reactions |
| 04/13/2010 | CA2447636C Synthesis of cannabinoids |
| 04/13/2010 | CA2380805C Improved topical medicaments and methods for photodynamic treatment of disease |
| 04/08/2010 | WO2010037886A1 Chroman derivatives and uses thereof as inhibitors of the activity of decoupling proteins |
| 04/08/2010 | US20100087634 Fluorous Oligonucleotide Reagents and Affinity Purification of Oligonucleotides |
| 04/08/2010 | US20100087518 Delta 9 - tetrahydrocannabinol processing |
| 04/08/2010 | US20100087320 Arylphenyl-substituted cyclic keto-enols |
| 04/07/2010 | EP2170857A2 3',4',5-trimethoxy flavone derivatives as stimulant of mucus secretion, method of the same, and pharmaceutical composition comprising the same |
| 04/07/2010 | EP1590340B1 Inhibitors of histone deacetylase |
| 04/07/2010 | CN101691591A Industrial preparation method of theaflavin |
| 04/06/2010 | US7691900 nervous system disorders; by reducing activation of the microglia an/or astrocytes and/or by reducing reactive gliosis; |
| 04/06/2010 | US7691899 non-peptide molecules, comprising side chains of amino acids, capable of adopting a helicoidal structure independent of the primary structure of the molecules; mimics active natural helices |
| 04/06/2010 | CA2334068C A method of chromatographic isolation for vitamin e isomers |
| 04/01/2010 | WO2010037127A1 Chromenone analogs as sirtuin modulators |
| 04/01/2010 | WO2010034927A1 Method for preparing nebivolol |
| 04/01/2010 | WO2010034243A1 Novel gene cluster |
| 04/01/2010 | WO2009116883A3 Catalytic asymetric hydrogenation |
| 04/01/2010 | US20100081832 Composition for treating cancer cells and preparation method for the same |
| 04/01/2010 | US20100081203 Fluorescent isotope tags and their method of use |
| 04/01/2010 | US20100081162 Method of evaluating antiwrinkle substance and method of assessing the skin |
| 04/01/2010 | CA2738794A1 Chromenone analogs as sirtuin modulators |
| 04/01/2010 | CA2736600A1 Method for preparing nebivolol |
| 03/31/2010 | EP2167483A1 Process for preparing chroman derivatives |
| 03/31/2010 | EP2167471A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| 03/31/2010 | CN101687835A Hydroxy sulfonate of quinone compounds and their uses |
| 03/31/2010 | CN101684131A Method for extracting tea polyphenol from tea leaves |
| 03/31/2010 | CN101684113A 7-carboxymethyloxy-3',4',5-trimethoxy flavone monohydrate, the preparation method and uses thereof |
| 03/31/2010 | CN101684112A Preparation method of 5,6,7,4'-tetramethoxy flavones of scutellarin and aglucone key intermediate thereof |
| 03/31/2010 | CN101683353A Preparation method and application of flavone and flavan derivatives |